|
|
Blood, 15 June 2008, Vol. 111, No. 12, pp. 5592-5600.
Prepublished online as a Blood First Edition Paper on April 7, 2008; DOI 10.1182/blood-2007-10-113951.
Previous Article | Next Article 
Submitted October 11, 2007
Accepted March 31, 2008
Genotype-phenotype correlation in combined deficiency of factor V and factor VIII
Bin Zhang*, Marta Spreafico, Chunlei Zheng, Angela Yang, Petra Platzer, Michael U Callaghan, Zekai Avci, Namik Ozbek, Johnny Mahlangu, Tabitha Haw, Randal J Kaufman, Kandice Marchant, EGD Tuddenham, Uri Seligsohn, Flora Peyvandi, and David Ginsburg
Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, United States
A. Bianchi Bonomi Hemophilia & Thrombosis Centre, Univ of Milan, and Dept of Medicine & Medical Spec, Luigi Villa Foundation, IRCCS Maggiore Hospital, Mangiagalli & Regina Elena Foundation, Milan, Italy
Life Sciences Institute, Depts of Internal Medicine and Human Genetics, University of Michigan, Ann Arbor, MI, United States
Children's Hospital of Michigan, Wayne State University, Detroit, MI, United States
Department of Pediatric Hematology, Baskent University Faculty of Medicine, Ankara, Turkey
National Health Laboratory Service, and University of the Witwatersrand, Johannesburg, South Africa
Departments of Biological Chemistry and Internal Medicine, University of Michigan, Ann Arbor, MI, United States
Pathology and Lab Medicine Division, Cleveland Clinic Foundation, Cleveland, OH, United States
Hemophilia Centre and Haemostasis Unit, Royal Free Hospital, London, United Kingdom
Institute of Thrombosis & Hemostasis, Sheba Medical Center, Tel-Hashomer, Israel
Life Sciences Institute, Dept of Internal Medicine and Human Genetics, University of Michigan, Ann Arbor, MI, United States
* Corresponding author; email: zhangb{at}ccf.org.
Combined deficiency of factor V and factor VIII (F5F8D) is caused by mutations in one of two genes, either LMAN1 or MCFD2. Here we report the identification of mutations for 11 additional F5F8D families, including 4 novel mutations, 2 in MCFD2 and 2 in LMAN1. We show that a novel MCFD2 missense mutation identified here (D81Y) and 2 previously reported mutations (D89A and D122V) abolish MCFD2 binding to LMAN1. Measurement of platelet factor V (FV) levels in 7 F5F8D patients (4 with LMAN1 and 3 with MCFD2 mutations), demonstrated similar reductions to those observed for plasma FV. Combining the current data together with all previous published reports, we performed a genotype-phenotype analysis comparing patients with MCFD2 mutations to those with LMAN1 mutations. A previously unappreciated difference is observed between these two classes of patients in the distribution of plasma levels for FV and factor VIII (FVIII). Although there is considerable overlap, the mean levels of plasma FV and FVIII in patients with MCFD2 mutations are significantly lower than the corresponding levels in patients with LMAN1 mutations. No differences in distribution of factor levels are observed by gender. These data suggest that MCFD2 may play a primary role in the export of FV and FVIII from the ER, with the impact of LMAN1 mediated indirectly through its interaction with MCFD2.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
|
|